Catechol-O-Methyltransferase Inhibitor class drugs
4 results
Entacapone (entacapone)
(Entacapone)Ajanta Pharma USA Inc.
Usage: Entacapone tablets are indicated as an adjunct therapy to levodopa and carbidopa for treating end-of-dose "wearing-off" in patients with Parkinson's disease. Its effectiveness has not been established in patients without this symptom.
Entacapone (entacapone)
(Entacapone)AvPAK
Usage: Entacapone tablets are indicated as an adjunct therapy to levodopa and carbidopa for treating end-of-dose "wearing-off" in Parkinson’s disease patients. Its effectiveness has not been evaluated in those without this specific symptom.
Ongentys (opicapone)
(opicapone)Neurocrine Biosciences, Inc.
Usage: ONGENTYS is indicated as an adjunctive treatment for patients with Parkinson's disease who experience "off" episodes while on levodopa/carbidopa therapy.
Tolcapone (tolcapone)
(tolcapone)Ingenus Pharmaceuticals, LLC
Usage: Tolcapone tablets are indicated as an adjunct to levodopa and carbidopa for treating symptoms of idiopathic Parkinson's disease in patients experiencing fluctuations. It should be used in those not responding to other therapies, with monitoring for liver injury and withdrawal if no significant benefit occurs within three weeks.